Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
eBay
EBAY
5
DOMINOS PIZZA ENTERPRISES LIMITED UNSP ADR EACH REPR 0.5 ORD SHS
DMZPY
US OptionsDetailed Quotes
HIMS250502C31000
- 10.00
- 0.000.00%
15min DelayClose May 2 16:00 ET
0.00High0.00Low
0.00Open10.00Pre Close0 Volume2.43K Open Interest31.00Strike Price0.00Turnover5796.84%IV-17.12%PremiumMay 2, 2025Expiry Date18.47Intrinsic Value100Multiplier-3DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type0.9602Delta0.0133Gamma4.95Leverage Ratio-95.4325Theta0.0000Rho4.75Eff Leverage0.0001Vega
Hims & Hers Health Newsroom
Hims & Hers Health Analyst Ratings
Piper Sandler Remains a Hold on Hims & Hers Health (HIMS)
Sell Rating for Hims & Hers Health Amid Growth Challenges and Market Uncertainties
Piper Sandler Maintains Hims & Hers Health(HIMS.US) With Hold Rating, Raises Target Price to $35
BofA Securities Maintains Hims & Hers Health(HIMS.US) With Sell Rating, Raises Target Price to $26
Sell Rating Maintained for Hims & Hers Health Amid Market Concerns Despite Strategic Partnership With Novo Nordisk
TD Cowen Downgrades Hims & Hers Health(HIMS.US) to Hold Rating, Raises Target Price to $30
Citi Maintains Hims & Hers Health(HIMS.US) With Sell Rating, Maintains Target Price $25
Morgan Stanley Maintains Hims & Hers Health(HIMS.US) With Hold Rating, Cuts Target Price to $40
Hims & Hers Health Is Maintained at Equal-Weight by Morgan Stanley
Hims & Hers Health Analyst Ratings
Hold Rating on Hims & Hers Health: Limited Near-Term Catalysts Amid Economic Challenges
Truist Financial Maintains Hims & Hers Health(HIMS.US) With Hold Rating
Needham Maintains Hims & Hers Health(HIMS.US) With Buy Rating, Cuts Target Price to $31
Analysts Offer Insights on Healthcare Companies: Centene (CNC), CareCloud (CCLD) and Hims & Hers Health (HIMS)
Hims & Hers Health Is Maintained at Sell by Citigroup
Hims & Hers Health Analyst Ratings
BofA Securities Maintains Hims & Hers Health(HIMS.US) With Sell Rating, Maintains Target Price $22
Sell Rating Issued for Hims & Hers Health Amid FDA Concerns on Topical Finasteride
BofA Securities Maintains Hims & Hers Health(HIMS.US) With Sell Rating, Maintains Target Price $22
Market Insights
Discussing
Berkshire 2025 highlights: Stepping aside as CEO, trade and market volatility
$Berkshire Hathaway-A (BRK.A.US)$ held its highly anticipated annual shareholders meeting Saturday. Here are some key takeaways from the eve
Buffettttttt
May 3 21:00
Berkshire's 2025 Annual Shareholders Meeting
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Unlock Now
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Unlock Now
